Barnes Dennig Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$775K Sell
646
-22
-3% -$22.5K 0.62% 35
2026
Q1
$614K Sell
668
-2
-0.3% -$2.03K 0.61% 37
2025
Q4
$720K Buy
670
+42
+7% +$40.2K 0.72% 35
2025
Q3
$479K Buy
628
+13
+2% +$9.67K 0.51% 45
2025
Q2
$479K Buy
615
+196
+47% +$152K 0.57% 41
2025
Q1
$346K Buy
+419
New +$349K 0.52% 35

Other funds holding LLY

Barnes Dennig Private Wealth Management's LLY Position: Q2 2026 in Review

Barnes Dennig Private Wealth Management reduced its Eli Lilly (LLY) stake by 3.3% in Q2 2026, selling an estimated $22.5K and leaving 646 shares worth $775K. The position accounts for 0.62% of the portfolio, ranked #35.

Barnes Dennig Private Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Barnes Dennig Private Wealth Management held 646 shares of Eli Lilly worth $775K as of Q2 2026.
  • Barnes Dennig Private Wealth Management sold 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.62% of Barnes Dennig Private Wealth Management's portfolio in Q2 2026, its #35 holding.
  • Barnes Dennig Private Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Barnes Dennig Private Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.